{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:42Z","timestamp":1788412482456,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Esophageal cancer is a highly invasive malignancy that severely impairs normal digestive function and poses a substantial threat to patient survival. The pathogenesis of miRNA-mediated tumors has been widely documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Verifying the involvement of miR-335-3p in the pathogenesis of esophageal squamous cell carcinoma (ESCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study enrolled 90 ESCC patients, from whom clinical data and pathological tissue samples were acquired. The prognostic potential of dysregulated miR-335-3p in ESCC was assessed using the Kaplan-Meier method. miR-335-3p and GFPT1 expression in the specimens were measured by RT-qPCR. Cellular biological functions were verified through transfection, CCK-8, Transwell, and kit-based assays. The targeting relationship was ascertained by luciferase activity assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>miR-335-3p was downregulated in ESCC, which is indicative of poorer prognostic outcomes. GFPT1 was up-regulated and was regarded as a target of miR-335-3p. Increased miR-335-3p levels markedly impaired cellular biological functions. Conversely, simultaneous overexpression of GFPT1 alleviated the negative effects induced by miR-335-3p mimic, which was associated with the partial restoration of cell activity and antioxidant capacity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>miR-335-3p represents a potential independent prognostic marker in ESCC. The anti-tumor activity induced by miR-335-3p overexpression may be associated with its regulation of GFPT1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00702-w","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:35:26Z","timestamp":1784637326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-335-3p acts as a tumor suppressor in esophageal squamous cell carcinoma and predicts favorable prognosis"],"prefix":"10.1186","volume":"163","author":[{"given":"Miao","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuojun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"702_CR1","doi-asserted-by":"publisher","first-page":"1450927","DOI":"10.3389\/fimmu.2024.1450927","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Li B, Liang L, Han J, Mai S, Liu L. From microbes to medicine: harnessing the power of the microbiome in esophageal cancer. Front Immunol. 2024;15:1450927.","journal-title":"Front Immunol"},{"issue":"1","key":"702_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12885-025-13483-8","volume":"25","author":"W Cao","year":"2025","unstructured":"Cao W, Jin D, Min W, Li H, Wang R, Zhang J, et al. Prognostic values of intracellular cell-related genes in esophageal cancer and their regulatory mechanisms. BMC Cancer. 2025;25(1):105.","journal-title":"BMC Cancer"},{"issue":"3","key":"702_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"2","key":"702_CR4","first-page":"100041","volume":"1","author":"Z Lu","year":"2020","unstructured":"Lu Z, Peng Z, Liu C, Wang Z, Wang Y, Jiao X, et al. Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers. Innov (Cambridge (Mass)). 2020;1(2):100041.","journal-title":"Innov (Cambridge (Mass))"},{"key":"702_CR5","doi-asserted-by":"publisher","first-page":"e8831","DOI":"10.7717\/peerj.8831","volume":"8","author":"X Guan","year":"2020","unstructured":"Guan X, Yao Y, Bao G, Wang Y, Zhang A, Zhong X. Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma. PeerJ. 2020;8:e8831.","journal-title":"PeerJ"},{"issue":"12","key":"702_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000535183","volume":"46","author":"X Fan","year":"2023","unstructured":"Fan X, Wang S, Pan K, Wang D, Wang R, Selective. COX-2 Inhibitor Is Beneficial in Suppressing Chronic Postsurgical Pain in Esophageal Cancer Patients and May Prolong Patient Survival. Oncol Res Treat. 2023;46(12):503\u201310.","journal-title":"Oncol Res Treat"},{"key":"702_CR7","doi-asserted-by":"publisher","first-page":"e060323214360","DOI":"10.2174\/1874467216666230306101653","volume":"17","author":"Z Ma","year":"2024","unstructured":"Ma Z, Zhu T, Wang H, Wang B, Fu L, Yu G. E2F1 Reduces Sorafenib\u2019s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p\/COL11A1 Signaling Axis. Curr Mol Pharmacol. 2024;17:e060323214360.","journal-title":"Curr Mol Pharmacol"},{"key":"702_CR8","doi-asserted-by":"publisher","first-page":"e18761429322420","DOI":"10.2174\/0118761429322420241112051105","volume":"17","author":"S Fatima","year":"2024","unstructured":"Fatima S, Song Y, Zhang Z, Fu Y, Zhao R, Malik K, et al. Exploring the Pharmacological Mechanisms of P-hydroxylcinnamaldehyde for Treating Gastric Cancer: A Pharmacological Perspective with Experimental Confirmation. Curr Mol Pharmacol. 2024;17:e18761429322420.","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"702_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2174\/0109298665315841240731060636","volume":"31","author":"X Deng","year":"2024","unstructured":"Deng X, Ma N, He J, Xu F, Zou G. The Role of TGFBR3 in the Development of Lung Cancer. Protein Pept Lett. 2024;31(7):491\u2013503.","journal-title":"Protein Pept Lett"},{"issue":"9","key":"702_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"Ye W, Wang J, Zheng J, Jiang M, Zhou Y, Wu Z. Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis. Protein Pept Lett. 2024;31(9):706\u201313.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"702_CR11","doi-asserted-by":"publisher","first-page":"19177","DOI":"10.1038\/s41598-025-03945-1","volume":"15","author":"X Shen","year":"2025","unstructured":"Shen X, Li B, Chen Y, Wang Y, Zhou W, Deng M, et al. Exploration of the potential therapeutic effects and targets of Coriandrum sativum on non-erosive esophagitis based on bioinformatics and molecular dynamics simulation. Sci Rep. 2025;15(1):19177.","journal-title":"Sci Rep"},{"issue":"6","key":"702_CR12","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.32604\/or.2025.060151","volume":"33","author":"N Bedolla","year":"2025","unstructured":"Bedolla N, Wu H, Liu L, Liu X, Ren Y. Gallic acid suppresses esophageal squamous cell carcinoma progression and enhances cisplatin chemosensitivity through IL-6\/STAT3\/Notch pathway. Oncol Res. 2025;33(6):1473\u201384.","journal-title":"Oncol Res"},{"key":"702_CR13","doi-asserted-by":"crossref","unstructured":"Seyhan AA. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges. Int J Mol Sci. 2023;24(17):13340.","DOI":"10.3390\/ijms241713340"},{"issue":"1","key":"702_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12951-022-01568-6","volume":"20","author":"X Gao","year":"2022","unstructured":"Gao X, Wu H, Li Y, Zhang L, Song M, Fu X, et al. Dancing in local space: rolling hoop orbital amplification combined with local cascade nanozyme catalytic system to achieve ultra-sensitive detection of exosomal miRNA. J Nanobiotechnol. 2022;20(1):357.","journal-title":"J Nanobiotechnol"},{"key":"702_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.semcancer.2021.05.004","volume":"76","author":"AP Ferragut Cardoso","year":"2021","unstructured":"Ferragut Cardoso AP, Banerjee M, Nail AN, Lykoudi A, States JC. miRNA dysregulation is an emerging modulator of genomic instability. Sem Cancer Biol. 2021;76:120\u201331.","journal-title":"Sem Cancer Biol"},{"issue":"9","key":"702_CR16","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.18632\/aging.204713","volume":"15","author":"YX Xie","year":"2023","unstructured":"Xie YX, Zhou ZH, Liu SW, Zhang Y, Liu WJ, Zhang RK, et al. microRNA-497 slows esophageal cancer development and reverses chemotherapy resistance through its target QKI. Aging. 2023;15(9):3791\u2013806.","journal-title":"Aging"},{"issue":"5\u20137","key":"702_CR17","doi-asserted-by":"publisher","first-page":"152190","DOI":"10.1016\/j.acthis.2024.152190","volume":"126","author":"J Xun","year":"2024","unstructured":"Xun J, Ma Y, Wang B, Jiang X, Liu B, Gao R, et al. RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4\/PI3K\/AKT signaling. Acta Histochem. 2024;126(5\u20137):152190.","journal-title":"Acta Histochem"},{"key":"702_CR18","doi-asserted-by":"crossref","unstructured":"Tan Z, Li W, Cheng X, Zhu Q, Zhang X. Non-Coding RNAs in the Regulation of Hippocampal Neurogenesis and Potential Treatment Targets for Related Disorders. Biomolecules. 2022;13(1):18.","DOI":"10.3390\/biom13010018"},{"issue":"15","key":"702_CR19","doi-asserted-by":"publisher","first-page":"19306","DOI":"10.18632\/aging.203272","volume":"13","author":"L Jin","year":"2021","unstructured":"Jin L, Luo C, Wu X, Li M, Wu S, Feng Y. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p. Aging. 2021;13(15):19306\u201316.","journal-title":"Aging"},{"issue":"9","key":"702_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/bbb\/zbab116","volume":"85","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wang X, Wu J, Xiao R, Liu J. MiR-335-3p inhibits cell proliferation and induces cell cycle arrest and apoptosis in acute myeloid leukemia by targeting EIF3E. Biosci Biotechnol Biochem. 2021;85(9):1953\u201361.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"2","key":"702_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10142-023-01041-z","volume":"23","author":"P Pandey","year":"2023","unstructured":"Pandey P, Suyal G, Aprajita, Pasbola K, Sharma R. NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells. Funct Integr Genom. 2023;23(2):111.","journal-title":"Funct Integr Genom"},{"key":"702_CR22","doi-asserted-by":"publisher","first-page":"1502206","DOI":"10.3389\/fimmu.2024.1502206","volume":"15","author":"L Tan","year":"2024","unstructured":"Tan L, Yang G, Zeng C, Zhang X. Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series. Front Immunol. 2024;15:1502206.","journal-title":"Front Immunol"},{"issue":"1","key":"702_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1124\/jpet.122.001234","volume":"384","author":"GM Traber","year":"2023","unstructured":"Traber GM, Yu AM. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. J Pharmacol Exp Ther. 2023;384(1):133\u201354.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"702_CR24","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s11010-024-05135-5","volume":"480","author":"M Dey","year":"2025","unstructured":"Dey M, Skipar P, Bartnik E, Pi\u0105tkowski J, Sulejczak D, Czarnecka AM. MicroRNA signatures in osteosarcoma: diagnostic insights and therapeutic prospects. Mol Cell Biochem. 2025;480(4):2065\u201375.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"702_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-022-01615-8","volume":"21","author":"Y Xi","year":"2022","unstructured":"Xi Y, Shen Y, Wu D, Zhang J, Lin C, Wang L, et al. CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer. 2022;21(1):145.","journal-title":"Mol Cancer"},{"issue":"7","key":"702_CR26","first-page":"2809","volume":"23","author":"DL Han","year":"2019","unstructured":"Han DL, Wang LL, Zhang GF, Yang WF, Chai J, Lin HM, et al. MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase. Eur Rev Med Pharmacol Sci. 2019;23(7):2809\u201316.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"702_CR27","doi-asserted-by":"publisher","first-page":"2285780","DOI":"10.1080\/08941939.2023.2285780","volume":"36","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, Chen L, Ni L. Association of miR-203 Expression with Prognostic Value in Patients with Esophageal Cancer: A Systematic Review and Meta-Analysis. J Invest surgery: official J Acad Surg Res. 2023;36(1):2285780.","journal-title":"J Invest surgery: official J Acad Surg Res"},{"key":"702_CR28","doi-asserted-by":"publisher","first-page":"1071627","DOI":"10.1155\/2022\/1071627","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li T, Peng C, Mao Q, Shen B, Shi M, et al. Knockdown of Long Noncoding RNA LINC00240 Inhibits Esophageal Cancer Progression by Regulating miR-26a-5p. Contrast Media Mol Imaging. 2022;2022:1071627.","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"702_CR29","doi-asserted-by":"publisher","first-page":"20240912","DOI":"10.1515\/med-2024-0912","volume":"19","author":"Z Ju","year":"2024","unstructured":"Ju Z, Cui F, Mao Z, Li Z, Yi X, Zhou J, et al. miR-335-3p improves type II diabetes mellitus by IGF-1 regulating macrophage polarization. Open Med (Warsaw Poland). 2024;19(1):20240912.","journal-title":"Open Med (Warsaw Poland)"},{"key":"702_CR30","doi-asserted-by":"crossref","unstructured":"Xia Z, Yang X, Zheng Y, Yi G, Wu S. Plasma Levels and Diagnostic Significance of miR-335-3p and EGFR in Diabetic Retinopathy. Clin Lab. 2022;68(4):689-698.","DOI":"10.7754\/Clin.Lab.2021.210447"},{"key":"702_CR31","doi-asserted-by":"crossref","unstructured":"Chen L, Shi Y, Li J, Yang X, Li R, Zhou X et al. LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335-3p\/TRAF5 axis. Anticancer Drugs. 2020:1-13.","DOI":"10.1097\/CAD.0000000000001001"},{"issue":"1","key":"702_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13046-024-03197-3","volume":"43","author":"V Di Paolo","year":"2024","unstructured":"Di Paolo V, Paolini A, Galardi A, Gasparini P, De Cecco L, Colletti M, et al. Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma. J experimental Clin cancer research: CR. 2024;43(1):282.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"1","key":"702_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13019-019-0883-1","volume":"14","author":"G Lin","year":"2019","unstructured":"Lin G, Liu H, Li J. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience. J Cardiothorac Surg. 2019;14(1):58.","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"702_CR34","doi-asserted-by":"publisher","first-page":"e23582","DOI":"10.1016\/j.heliyon.2023.e23582","volume":"10","author":"Y Liang","year":"2024","unstructured":"Liang Y, He S, Tan Y, Liu Q, Zhao F, Liu T, et al. In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized. Heliyon. 2024;10(1):e23582.","journal-title":"Heliyon"},{"key":"702_CR35","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhang J, Zhang X, Liu S, Qi C, Gao S. miR\u2013100: A key tumor suppressor regulatory factor in human malignant tumors (Review). Int J Mol Med. 2025;55(4):67.","DOI":"10.3892\/ijmm.2025.5508"},{"issue":"1","key":"702_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12957-021-02147-z","volume":"19","author":"Y Gong","year":"2021","unstructured":"Gong Y, Qian Y, Luo G, Liu Y, Wang R, Deng S, et al. High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma. World J Surg Oncol. 2021;19(1):35.","journal-title":"World J Surg Oncol"},{"issue":"10","key":"702_CR37","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/carcin\/bgac073","volume":"43","author":"D Li","year":"2022","unstructured":"Li D, Guan M, Cao X, Zha ZQ, Zhang P, Xiang H, et al. GFPT1 promotes the proliferation of cervical cancer via regulating the ubiquitination and degradation of PTEN. Carcinogenesis. 2022;43(10):969\u201379.","journal-title":"Carcinogenesis"},{"issue":"1","key":"702_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11(1):36.","journal-title":"Nat Commun"},{"issue":"4","key":"702_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/MPA.0000000000001790","volume":"50","author":"RL Massoumi","year":"2021","unstructured":"Massoumi RL, Teper Y, Ako S, Ye L, Wang E, Hines OJ, et al. Direct Effects of Lipopolysaccharide on Human Pancreatic Cancer Cells. Pancreas. 2021;50(4):524\u20138.","journal-title":"Pancreas"},{"issue":"9","key":"702_CR40","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1515\/hsz-2019-0430","volume":"401","author":"C Zhang","year":"2020","unstructured":"Zhang C, Lian H, Xie L, Yin N, Cui Y. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biol Chem. 2020;401(9):1053\u201361.","journal-title":"Biol Chem"},{"issue":"1","key":"702_CR41","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1186\/s12885-024-12811-8","volume":"24","author":"W Tang","year":"2024","unstructured":"Tang W, Gao Y, Hong S, Wang S. GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation. BMC Cancer. 2024;24(1):1071.","journal-title":"BMC Cancer"},{"issue":"1","key":"702_CR42","doi-asserted-by":"publisher","first-page":"23494","DOI":"10.1038\/s41598-024-74247-1","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Yang H, Qi Y, Yu P, Han X, Zhang Z, et al. CISD3 is a prognostic biomarker and therapeutic target in pan-cancer. Sci Rep. 2024;14(1):23494.","journal-title":"Sci Rep"},{"key":"702_CR43","doi-asserted-by":"publisher","first-page":"153954","DOI":"10.1016\/j.prp.2022.153954","volume":"236","author":"S Zheng","year":"2022","unstructured":"Zheng S, Liu T, Li L, Liu Q, Yang L, Zhang Q, et al. Tumor-infiltrating lymphocyte signature in epithelial and stromal compartments of an esophageal squamous cell carcinoma acidic microenvironment mediated by MCT4. Pathol Res Pract. 2022;236:153954.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"702_CR44","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1002\/jcp.30236","volume":"236","author":"S Zheng","year":"2021","unstructured":"Zheng S, Shen T, Liu Q, Liu T, Tuerxun A, Zhang Q, et al. CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway. J Cell Physiol. 2021;236(7):5373\u201386.","journal-title":"J Cell Physiol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00702-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00702-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00702-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:23:55Z","timestamp":1788409435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00702-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00702-w","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Jiujiang First People\u2019s Hospital before the study began. The written informed consent has been obtained from the participants involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"93"}}